ArticleScientific reports2025
The association between 24-hour urinary biomarkers and metabolic syndrome: A cross-sectional study in zhejiang, China.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Metabolic syndrome (MetS) is a cluster of metabolic disorders associated with increased risks of cardiovascular diseases and type 2 diabetes, posing a significant public health challenge globally. Early identification of biomarkers for MetS is crucial for timely intervention. This study aimed to explore the association between 24-hour urine indicators (sodium, potassium, creatinine, and microalbumin) and MetS among Chinese adults, providing evidence for early MetS screening and intervention. A cross-sectional survey was conducted in 2017, involving 1175 Chinese residents aged 18-69 years. Data were collected via questionnaires, physical measurements, and laboratory tests, with 24-hour urine samples analyzed for sodium, potassium, creatinine, and microalbumin excretion. Participants were excluded if they had incomplete data, unqualified urine collection, or a self-reported history of hypertension or diabetes. Of the 1175 participants (median age 42 years; 48.17% male), the prevalence of MetS was 11.4%. The median 24-hour urine excretion levels were 158.42/24 hours mmol (sodium), 34.89 mmol/24 hours (potassium), 9.62 mmol/24 hours (creatinine), and 4.31 mg/24 hours (microalbumin). Specifically, 24-hour urine microalbumin excretion was significantly higher in participants with MetS (6.35 mg/24 h) than in those without (4.12 mg/24 h; P < 0.0001), while no significant differences were observed in sodium, potassium, or creatinine excretion between the two groups. Notably, elevated microalbumin excretion was associated with MetS components: central obesity, elevated blood pressure, elevated fasting blood glucose, and elevated triglycerides (all P < 0.05). When microalbumin excretion was divided into quartiles, adjusted odds ratios (adjusted for age, sex, and other confounders) for MetS and its component (elevated fasting blood glucose) increased with higher quartiles (MetS: 1.00, 1.53, 1.99, 2.75; P for trend = 0.0004; elevated fasting blood glucose: 1.00, 1.31, 1.35, 2.20; P for trend = 0.0005). These findings indicate that elevated 24-hour urine microalbumin excretion is independently associated with MetS in Chinese adults, suggesting its potential as a practical biomarker for early risk assessment and intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.